LMG Life Sciences Awards EMEA 2023 shortlist revealed
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2023 shortlist revealed


The LMG Life Sciences Awards is excited to announce its shortlist for the 2023 EMEA Awards.

The LMG Life Sciences Awards has released the full list of finalists for the 2023 EMEA awards.

The awards bring together Europe’s legal community to recognise the leading law firms and lawyers from across the region to celebrate their success in the Life Sciences industry.

Winners will be announced at the black-tie gala celebration which will be held on 13 July 2023 at the Waldorf Hilton.

A preview of the finalists can be found below and the full list of the finalists for all categories is available on the LMG Life Sciences website. The LMG Life Sciences Awards research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, client feedback, and much deliberation.

Individual practitioners and Rising Stars are judged not only on the complexity of the work the nominees completed in 2022, but also on their advocacy, influence, and thought leadership.

All of the work accepted for shortlisting closed during the research period, which was from January 1 to December 31 2022. The awards do not recognise cases, deals, or transactions completed outside of the research period.

If you have any questions regarding our research process, please contact our editor John Harrison

The LMG Life Sciences Awards will be announcing the winners on July 13 at a live awards gala. To find out more – and to find out about how you can promote your success – please contact Prin Shasiharan.

Preview of the LMG Life Sciences Awards EMEA 2023 shortlist:

  • Patent Litigation Firm of the Year: Biologics & Biosimilars

    Allen & Overy
    Carpmaels & Ransford
    Herbert Smith Freehills
    Pestalozzi Attorneys at Law
    Powell Gilbert
    Taylor Wessing
  • Patent Strategy & Management Firm of the Year

    Bird & Bird
    Deris Attorney at Law Partnership
    Dimitrov Petrov & Co
    Greenberg Traurig
    Kiortsis & Associates
    NSN Law Firm
    The Luzzatto Group
  • Patent Litigator of the Year: Biologics & Biosimilars

    Andreas Seling
    Andri Hess
    David Wilson
    Carpmaels & Ransford
    Emre Kerim Yardimci
    Deris Attorney at Law Partnership
    Laura Orlando
    Herbert Smith Freehills
    Patricia Cappuyns
    Taylor Wessing
    Zoe Butler
    Powell Gilbert

LMG Life Sciences is a sister publication to Managing IP, and is run independently from IP Stars research.

more from across site and ros bottom lb

More from across our site

The FRAND rate is only 5 cents higher than the per-device rate determined at first instance in 2023
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Nearly four months after joining Crowell & Moring, Edward Taelman reflects on starting afresh, new clients, and firm culture
Firms discuss the ebb and flow of life sciences IP work and explain how they help professionals pivot between specialities
Mercedes-Benz, Dolby Laboratories, and Panasonic discuss the merits and drawbacks of the USPTO's terminal disclaimer proposal
In-house counsel believe Chinese domestic firms are becoming as sophisticated as international firms, but they may not shift their portfolios just yet
The Court of Appeals for the Federal Circuit is looking to renew a ban that has prevented Judge Pauline Newman from hearing cases
The list of the top representative firms at the UPC may yield few surprises but their success did not come free
The German firms have accounted for 26% of all infringement actions, while US corporations appear interested in litigating at the forum, a report has revealed
Vincent Brault tells us how he fits kitesurfing into his lunchtime routine and why IP is no longer seen as ‘nerdy’
Gift this article